We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00202800
First Posted: September 20, 2005
Last Update Posted: June 4, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Van Andel Research Institute
Eli Lilly and Company
Battle Creek Health System
Hackley Hospital
Metropolitan Hospital, Michigan
Mecosta County General Hospital
Munson Medical Center
Saint Mary's Health Care
Information provided by:
Spectrum Health Hospitals
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)